Spots Global Cancer Trial Database for hematologic
Every month we try and update this database with for hematologic cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis | NCT00323518 | Oral Mucositis Stomatitis | velafermin placebo | 18 Years - | Celldex Therapeutics | |
| Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory AML | NCT01191801 | Acute Myeloid L... | vosaroxin + cyt... placebo + cytar... | 18 Years - | Sunesis Pharmaceuticals | |
| Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies | NCT03838926 | Relapsed or Ref... | Trichostatin A | 18 Years - | Vanda Pharmaceuticals | |
| Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia | NCT00607997 | Leukemia Acute Disease Acute Myeloid L... Nonlymphocytic ... Myelodysplastic... | vosaroxin | 60 Years - | Sunesis Pharmaceuticals | |
| Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies | NCT03838926 | Relapsed or Ref... | Trichostatin A | 18 Years - | Vanda Pharmaceuticals | |
| PH2 Trial in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) With a Combination of Bendamustine & Ofatumumab | NCT01131247 | Chronic Lymphoc... | ofatumumab + be... | 18 Years - | Nevada Cancer Institute | |
| Health Counseling and Exercise in Patients With Acute Leukemia - Pilot Study | NCT01557686 | Acute Leukemia | Health counseli... | 18 Years - | Universitetshospitalernes Center for Sygepleje | |
| Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies | NCT00246662 | Leukemia, Lymph... Leukemia, Nonly... Leukemia, Myelo... Myelodysplastic... | Vosaroxin | 18 Years - | Sunesis Pharmaceuticals | |
| Health Counseling and Exercise in Patients With Acute Leukemia - Pilot Study | NCT01557686 | Acute Leukemia | Health counseli... | 18 Years - | Universitetshospitalernes Center for Sygepleje | |
| Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT | NCT01810120 | Acute Lymphobla... Leukemia Acute ... Non-Hodgkin Lym... Myelodysplastic... | TCR alfa beta T... | 3 Months - 20 Years | Bambino Gesù Hospital and Research Institute | |
| AMG 319 Lymphoid Malignancy FIH | NCT01300026 | Cancer Chronic Lymphoc... Diffuse Large C... Hematologic Mal... Hematology Leukemia Low Grade Lymph... Lymphoma Mantle Cell Lym... Non-Hodgkin's L... Oncology Oncology Patien... T Cell Lymphoma Tumors | AMG 319 | 18 Years - | Amgen | |
| Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory AML | NCT01191801 | Acute Myeloid L... | vosaroxin + cyt... placebo + cytar... | 18 Years - | Sunesis Pharmaceuticals | |
| Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory AML | NCT01191801 | Acute Myeloid L... | vosaroxin + cyt... placebo + cytar... | 18 Years - | Sunesis Pharmaceuticals | |
| A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies | NCT01036009 | Acute Leukemia Acute Myeloid L... Acute Lymphobla... Biphenotypic Le... Pre-leukemic Sy... Monosomy 7 Bone Marrow Clo... Juvenile Myelom... Myelodysplastic... Chronic Myeloge... | Withdrawal of i... | 6 Months - 25 Years | University of California, San Francisco | |
| AMG 319 Lymphoid Malignancy FIH | NCT01300026 | Cancer Chronic Lymphoc... Diffuse Large C... Hematologic Mal... Hematology Leukemia Low Grade Lymph... Lymphoma Mantle Cell Lym... Non-Hodgkin's L... Oncology Oncology Patien... T Cell Lymphoma Tumors | AMG 319 | 18 Years - | Amgen |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
